Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Nucleic Acids Res ; 32(1): 346-53, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-14726483

RESUMO

The nuclear antisense properties of a series of tricyclo (tc)-DNA oligonucleotide 9-15mers, targeted against the 3' and 5' splice sites of exon 4 of cyclophilin A (CyPA) pre-mRNA, were evaluated in HeLa cells and compared with those of corresponding LNA-oligonucleotides. While the 9mers showed no significant antisense effect, the 11-15mers induced exon 4 skipping and exon 3+4 double skipping to about an equal extent upon lipofectamine mediated transfection in a sequence- and dose-dependent manner, as revealed by a RT-PCR assay. The antisense efficacy of the tc-oligonucleotides was found to be superior to that of the LNA-oligonucleotides in all cases by a factor of at least 4-5. A tc-oligonucleotide 15mer completely abolished CyPA mRNA production at 0.2 microM concentration. The antisense effect was confirmed by western blot analysis which revealed a reduction in CyPA protein to 13% of its normal level. Fluorescence microscopic investigations with a fluorescein labeled tc-15mer revealed a strong propensity for homogeneous nuclear localization of this backbone type after lipofectamine mediated transfection, while the corresponding lna 15mer showed a less clear cellular distribution pattern. Transfection without lipid carrier showed no significant internalization of both tc- and LNA- oligonucleotides. The obtained results confirm the power of tc-DNA for nuclear antisense applications. Moreover, CyPA may become an interesting therapeutic target due to its important role in the early steps of the viral replication of HIV-1.


Assuntos
Ciclofilina A/genética , Oligonucleotídeos Antissenso/metabolismo , Precursores de RNA/metabolismo , Splicing de RNA/genética , Processamento Alternativo , Western Blotting , Núcleo Celular/genética , Núcleo Celular/metabolismo , Ciclofilina A/metabolismo , Regulação para Baixo , Éxons/genética , HIV-1/fisiologia , Células HeLa , Humanos , Lipídeos , Microscopia de Fluorescência , Conformação de Ácido Nucleico , Oligonucleotídeos Antissenso/química , Oligonucleotídeos Antissenso/genética , Precursores de RNA/genética , Sítios de Splice de RNA/genética , Estabilidade de RNA , Termodinâmica , Transfecção
2.
Nucleic Acids Res ; 32(12): 3752-9, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15254276

RESUMO

Human immunodeficiency virus 1 (HIV-1) multiplication depends on a cellular protein, cyclophilin A (CyPA), that gets integrated into viral particles. Because CyPA is not required for cell viability, we attempted to block its synthesis in order to inhibit HIV-1 replication. For this purpose, we used antisense U7 small nuclear RNAs (snRNAs) that disturb CyPA pre-mRNA splicing and short interfering RNAs (siRNAs) that target CyPA mRNA for degradation. With dual-specificity U7 snRNAs targeting the 3' and 5' splice sites of CyPA exons 3 or 4, we obtained an efficient skipping of these exons and a strong reduction of CyPA protein. Furthermore, short interfering RNAs targeting two segments of the CyPA coding region strongly reduced CyPA mRNA and protein levels. Upon lentiviral vector-mediated transduction, prolonged antisense effects were obtained for both types of antisense RNAs in the human T-cell line CEM-SS. These transduced CEM-SS cells showed a delayed, and for the siRNAs also reduced, HIV-1 multiplication. Since the two types of antisense RNAs function by different mechanisms, combining the two approaches may result in a synergistic effect.


Assuntos
Ciclofilina A/antagonistas & inibidores , HIV-1/fisiologia , RNA Antissenso/genética , RNA Interferente Pequeno/genética , RNA Nuclear Pequeno/antagonistas & inibidores , Linhagem Celular , Ciclofilina A/biossíntese , Ciclofilina A/genética , Éxons , Vetores Genéticos , Humanos , Lentivirus/genética , Interferência de RNA , Precursores de RNA/metabolismo , Splicing de RNA , Linfócitos T/virologia , Replicação Viral
3.
J Gene Med ; 9(5): 323-34, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17474072

RESUMO

The HIV-1 regulatory proteins Tat and Rev are encoded by multiply spliced mRNAs that differ by the use of alternative 3' splice sites at the beginning of the internal exon. If these internal exons are skipped, the expression of these genes, and hence HIV-1 multiplication, should be inhibited. We have previously developed a strategy, based on antisense derivatives of U7 small nuclear RNA, that allows us to induce the skipping of an internal exon in virtually any gene. Here, we have successfully applied this approach to induce a partial skipping of the Tat, Rev (and Nef) internal exons. Three functional U7 constructs were subcloned into a lentiviral vector. Two of them strongly reduced the efficiency of lentiviral particle production compared to vectors carrying either no U7 insert or unrelated U7 cassettes. This defect could be partly or fully compensated by coexpressing Rev from an unspliced mRNA in the producing cell line. Upon stable transduction into CEM-SS or CEM T-lymphocytes, the most efficient of these constructs inhibits HIV-1 multiplication. Although the inhibition is not complete, it is more efficient in combination with another mechanism inhibiting HIV multiplication. Therefore, this new approach targeting HIV-1 regulatory genes at the level of pre-mRNA splicing, in combination with other antiviral strategies, may be a useful new tool in the fight against HIV/AIDS.


Assuntos
Éxons , Genes Reguladores/efeitos dos fármacos , HIV-1/genética , RNA Nuclear Pequeno/farmacologia , Replicação Viral/efeitos dos fármacos , Linhagem Celular , Genes rev/efeitos dos fármacos , Genes tat/efeitos dos fármacos , Vetores Genéticos , Humanos , Splicing de RNA , Linfócitos T/virologia , Transdução Genética , Replicação Viral/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA